Companies: 10,795·Total market cap: $144.5T
Actinium Pharmaceuticals, Inc.

Actinium Pharmaceuticals, Inc.

ATNMAMEXHealthcare● Active
$1.06
$-0.02(-1.85%)
Market Cap$33257494
P/E Ratio
52W High$1.945
52W Low$0.952

Actinium Pharmaceuticals, Inc. (ATNM) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ATNM · as of Mar 30, 2026

Latest filing snapshot

25
-12-32.43%vs prior year

Actinium Pharmaceuticals, Inc. (ATNM) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
25
Change (1Y)
-12
Growth % (1Y)
-32.43%
Revenue / Employee
$3.6K
Net Income / Employee
$-1.36M
Market Cap
$33M

ATNM Employee Count

2008 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-3025-12-32.43%
2025-03-3137-12-24.49%
2024-03-2949+0+0.00%
2023-03-3149+17+53.13%
2022-03-2532+0+0.00%
2021-03-3132+7+28.00%
2020-05-0825-5-16.67%
2019-03-1530+5+20.00%
2018-03-1625+2+8.70%
2017-03-1623+5+27.78%

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
FibroGen, Inc.
FGEN
FibroGen, Inc.
225
#2
Kezar Life Sciences, Inc.
KZR
Kezar Life Sciences, Inc.
55
#3
OnKure Therapeutics, Inc.
OKUR
OnKure Therapeutics, Inc.
46
#4
LAVA Therapeutics N.V.
LVTX
LAVA Therapeutics N.V.
34
#5
Actinium Pharmaceuticals, Inc.
ATNM
Actinium Pharmaceuticals, Inc.YOU
25
#6
PDS Biotechnology Corporation
PDSB
PDS Biotechnology Corporation
24
#7
Annovis Bio, Inc.
ANVS
Annovis Bio, Inc.
8
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ATNM peer comparison

About ATNM employees

ATNM Employees · Headcount

Actinium Pharmaceuticals, Inc. (ATNM) employee data is sourced from the annual SEC 10-K filing. As of 2025, Actinium Pharmaceuticals, Inc. had 25 full-time employees globally. Full-time employees only. Global consolidated headcount.

Actinium Pharmaceuticals, Inc. employs 25 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $3,600, reflecting the company's operational efficiency.

Actinium Pharmaceuticals, Inc.'s workforce decreased by 12 (32.43%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Actinium Pharmaceuticals, Inc.'s revenue per employee of $3,600 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

ATNM Employees · 5 questions

As of the latest SEC 10-K filing (2025), Actinium Pharmaceuticals, Inc. had 25 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Actinium Pharmaceuticals, Inc. employee counthow many employees does Actinium Pharmaceuticals, Inc. haveATNM total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-30